A Burkitt lymphoblastoid cell line, P31-HR-I, was fused and hybridized to a human sternal marrow cell line. The somatic cell hybrids were negative when examined for Epstein-Barr virus (EBV) markers. When the hybrid cells were exposed to 5-iododeoxyuridine, both EBV-specific antigens and virus particles were induced as determined by the immunofluorescence test and by electron microscopy. The data presented suggest that the EBV genome can be transferred from a lymphoblastoid cell to another cell type during cell hybridization, that the EBV genome can persist in the hybrid cells for long periods of time, and that synthesis of the virus can be induced in the heterokaryons.
Inactivated Sendai virus has been used to induce cell fusion in several laboratories (7, 12, 21) . The procedure has been applied to cancer research where somatic cell hybridization (3, 15) has proven to be a fruitful technique in many studies. The rescue of simian virus 40 from transformed cells after they were fused to potentially susceptible cells (6, 16) has greatly stimulated use of the method in virus laboratories. The method, when applied to papovavirus systems, has already allowed observations that suggest that, in somatic cell hybrids of normal and virus-transformed cells, virus-specific tumor and transplantation antigens can be transferred into the hybrid and can persist in the hybrid cells for long periods of time (5, 26) .
The association of a herpesvirus designated the Epstein-Barr virus (EBV) with many human lymphoblastoid cell lines has been reported (8) . A small percentage of the cells contain the EBV (9) as well as antigens which can be detected by the immunofluorescence test (13) . There is also some evidence that the EBV genome is integrated in the host cell genome (19, 27) .
Recent findings have indicated that Burkitt lymphoblastoid cells can be fused and hybridized to both mouse and human cells (R. Glaser and F. J. O'Neill, Science, in press). In this report, further data is presented concerning the properties of the Burkitt lymphoblastoid somatic cell hybrids and the induction of synthesis of EBVspecific antigens and virus particles using the drug 5-iododeoxyuridine (IUDR).
MATERIALS AND METHODS
Cells. The human sternal marrow cell line, D98 ' AH-2, (D98) (25) was maintained in Eagle medium supplemented with 10%c,0 fetal calf serum, 100 units of penicillin/ml, 100 ,ug of streptomycin/ml, 1 jAg of fungizone,/ml, 10 units of mycostatin/ml, and 0.075% NaHCO3 in 8-oz (ca. 0.24 liter) glass prescription bottles at 37 C. The Burkitt lymphoblastoid cell line, P3J-HR-1, (HR-1) was maintained in RPM1 1640 medium supplemented with 10%-o fetal calf serum, 100 units of penicillin/ml, 100,ug of streptomycin/ml, 1 Mg of fungizone/ml, 10 units of mycostatin/nd, and 0.075c% NaHCO3 in 8- (14) overnight at 4 C. The specimens were postfixed for 2 hr with Dalton's chrome-osmium (4) (containing 2% osmium tetroxide), dehydrated, and embedded in Spurr's low-viscosity plastic (24) . Thin sections were prepared by using an LKB ultratome; the sections were stained with 0.5% uranyl acetate in 50%r0 methanol and Reynold's lead (22) Fig. 1 and 2) . The D98 cells were contact inhibited (Fig. 3) . In contrast, the D98/HR-1 cells were observed to grow frequently in multilayered foci (Fig. 4) To determine if the EBV antiserum used in the serum blocking experiments would block the immunologic reaction in a nonspecific manner, it was tested on rabbit kidney (RK) cells infected with herpes simplex virus type 2 (HSV-2). The EBV-positive serum was adsorbed on acetonefixed monolayer cell cultures of RK cells infected with HSV-2 (pretested with rabbit anti HSV-2 antiserum and found positive for HSV-2-specific antigens by immunofluorescence). The cells were then adsorbed with rabbit anti-HSV-2 antiserum followed by horse anti-rabbit antiserum conjugated to FITC. The EI3V-specific antiserum did not interfere with the detection of the HSV-2-specific antigens.
Synthesis of virus particles. When cultures of D98/HR-1 cells were examined at 3, 5, 7 and 10 days after seeding in tissue culture flasks, no virus particles were observed. However, when D98/ VOL." 10, 1972 HR-1 cells previously treated with IUDR were examined, virus particles were observed in the nuclei of degenerating cells on days 7 and 10 ( Fig. 7) . Both enveloped (in the cytoplasm) and unenveloped particles were found in many cells examined. In a second set of experiments, D98/HR-1 cells were pooled from several flasks and either seeded into tissue culture flasks or grown on cover slips. One set of flasks and cover slip monolayer cell cultures was treated with IUDR; the other set was not exposed to the drug. Seven days after removal of IUDR from the treated cultures, both sets of cell cultures were fixed for electron microscopy examination. The cover slip monolayer cells were fixed and examined by the direct immunofluorescence test, by the method already described.
The D98/HR-1 cells treated with IUDR contained virus particles in the nuclei of about 10%l, of the cells examined and some cells exhibited particles in the cytoplasm; however, no virus particles were observed in the untreated cells. When the specimens prepared for immunofluorescence were examined, the cells treated with IUDR contained EBV antigens as described previously. No EBV antigens or particles were detected in the untreated cells (Table 2) .
DISCUSSION
The results presented in this report and in a preliminary report (R. Glaser and F. J. O'Neill, Science, in press) suggest that Burkitt lymphoblastoid cells have been fused and hybridized with both mouse and human cells. The chromosome data, along with the alteration in cell morphology and ability to grow in a selective medium, were the criteria used to support evidence of somatic cell hybridization.
The data obtained from chromosome analysis from earlier work suggested that most, if not all, the HR-1 chromosomes were in the nuclei of the D98/HR-1 cells. In addition, EBV-specific anti- (2) .
Other investigators have reported the induction of EBV antigens in "normal" lymphoblastoid cell lines with BUDR (10) . In the presence of BUDR, both nuclear and cytoplasmic antigens were detected. In addition, ribonucleic acid (RNA) viruses have also been induced in cell lines with BUDR or IUDR (1, 18) . Thus, the results presented here concerning induction of EBV antigens in somatic cell hybrids reveal that induction of virus in hybrids may follow a pathway similar to that in virus-transformed cells.
The sera used in the indirect and direct immunofluorescence tests were known to be highly specific. There was no emperipolesis of the HR-1 cells by the D98 cells as determined by brightfield and phase-contrast microscopy, discounting the possibility of carry-over of lymphoblastoid cells. To further support this, no evidence of the persistence of HR-1 cells was found by visual observations and by chromosome analysis when the cells were cloned. Furthermore, the cells that are positive in the immunofluorescence test and by electron microscopy are epithelial-like in morphology.
Whether the D98/HR-1 cells are transformed is still not clear. The hybrid cells grow in multilayers, indicating a loss of contact inhibition. The D98 cells have never been observed to do this. However, further work is necessary to clarify this point.
The production of EBV particles in the IUDRtreated cells clearly shows that the EBV genome maintained in the hybrid cells are complete enough to code for EBV DNA and capsid proteins, since complete virus particles with dense cores were found. Whether enough information is present to code for the synthesis of "infectious" EBV with a higher oncogenic potential than the EBV presently obtained from lymphoblastoid cells remains to be determined. If infectious, the properties of this virus and its ability to replicate or transform various cell types will represent an important extension of this work. bAt 60 jig/ml for 3 days; cells were fixed for electron microscopy 7 days after the removal of IUDR (performed at 37 C).
